HBM Holdings Limited (HKG:2142)
Hong Kong
· Delayed Price · Currency is HKD 7.96
+0.07 (0.89%)
Jun 6, 2025, 4:08 PM HKT
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 6.33 billion as of June 6, 2025. Its market cap has increased by 505.73% in one year.
Market Cap
6.33B
Enterprise Value
5.51B
Revenue
295.94M
Ranking
n/a
PE Ratio
283.40
Stock Price
7.96
Market Cap Chart
Since December 10, 2020, HBM Holdings's market cap has decreased from 8.46B to 6.33B, a decrease of -25.17%. That is a compound annual growth rate of -6.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 6.33B | 364.79% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | 8.11B | -4.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 238.13B |
| Hansoh Pharmaceutical Group Company | 161.73B |
| JD Health International | 126.72B |
| Innovent Biologics | 120.66B |
| CSPC Pharmaceutical Group | 101.26B |
| WuXi Biologics | 100.29B |
| Sino Biopharmaceutical | 81.38B |
| Sichuan Kelun-Biotech Biopharmaceutical | 75.34B |